Legislature(2003 - 2004)
04/24/2003 02:18 PM House FIN
| Audio | Topic |
|---|
* first hearing in first committee of referral
+ teleconferenced
= bill was previously heard/scheduled
+ teleconferenced
= bill was previously heard/scheduled
SENATE BILL NO. 109
Department of Health and Social Services to apply to
administration of the medical assistance program when
there are insufficient funds allocated in the state
budget for that program; authorizing the department to
make cost containment decisions that may include
decisions about eligibility of persons and availability
of services under the medical assistance program; and
providing for an effective date.
JOEL GILBERTSON, COMMISSIONER, DEPARTMENT OF HEALTH & SOCIAL
SERVICES, explained that under current law, if funds
appropriated to the Medicaid program are insufficient for a
given fiscal year, the Department is directed to eliminate
optional Medicaid services based on a priority list that is
out-of-date. He maintained that the existing list is not an
effective management tool and if used, would result in the
denial of necessary and cost-effective services to Alaskans.
Commissioner Gilbertson advised that the bill would repeal
the options list and replaces it with a singular direction
for the Department to engage in cost containment measures to
achieve the same level savings to operate the Medicaid
Program within the amount appropriated by the Legislature.
The proposed bill would replace the obsolescent language
with broad general authority for the Department to undertake
cost containment based on three key principles:
· The Department must pursue all other reasonable
cost containment measures before eliminating any
eligibility groups or services;
· The Department should aggressively pursue
strategies to maximize federal financial
participation in the Medicaid program; and
· Cost containment decisions should be made in a
manner that best reflects the needs and interests
of eligible Medicaid recipients.
Commissioner Gilbertson noted that the current list in
statute establishes a very rigid structure. The
Administration believes that the Department can engage in
similar cost containment measures within the Medicaid
Program and conduct cost containment in a manner that is
responsive to the Legislature's intent and responsive to the
needs of the beneficiary population.
He spoke to the fiscal note. Commissioner Gilbertson stated
that next year there would be a savings. At this point, the
Administration is not proposing any additional cost
containment in the Medicaid Program that is not currently in
the Governor's budget mission.
Co-Chair Harris asked about a deferred drug list.
Commissioner Gilbertson advised that included in the
Governor's budget submission this year was a proposal for
adopting a deferred drug list for the Alaska Medical
Assistance Program. A preferred drug list is not a
formulary. That drug list is a peered reviewed,
professionally designed list that establishes preferred
drugs within a drug class. These drugs would be purchased
at a similar or lower cost. Some other states use these
drug lists. He added that at this stage, the Department has
not formulated their preferred drug list and are not in the
process of developing one. Commissioner Gilbertson did not
believe that the Department would develop their own list.
There are a number of other lists adopted by other states
that have withstood litigation. It is foreseeable that
Alaska would take one from another state. That decision has
not yet been made. He acknowledged that the preferred drug
list is contentious.
Co-Chair Harris inquired the success rate that other states
have had in saving money using this system.
Commissioner Gilbertson offered to provide that information
to the Committee at a later date. He added that some states
have shown large savings. There is disagreement regarding
the net effect of Medicaid expenditures. Most of the
Medicaid growth now is within the seniors and disabled
individual population area. Seniors have a high drug
utilization cost. The preferred drug list would not prevent
access to pharmaceutical products that perform certain
benefits. The Commission would decide which there might be
two drugs that serve the same purpose, which one should be
clinically approved for dispensing.
Co-Chair Harris requested that Commissioner Gilbertson work
with Representative Hawker and other interested parties who
have concerns regarding this legislation.
Co-Chair Williams recommended that Commissioner Gilbertson
also work with Representative Croft, the maker of the
proposed amendments.
Co-Chair Williams noted that SB 109 would be HELD in
Committee for further consideration.
| Document Name | Date/Time | Subjects |
|---|